Taxotere
5 stories tracked · latest
136
Case tracking for the Taxotere matter, current through August 11, 2026, plus any additional news coverage found automatically below. Allegations may be disputed; a listing does not establish liability or individual eligibility.
Recent coverage
Taxotere Eye Injury MDL Judge Finds Genuine Dispute On Adequacy Of Label Warning - Mealey's
A judge in the Taxotere eye-injury multidistrict litigation found a factual dispute over whether the drug's warning label was adequate.
Taxotere Lawsuit Attorney: 2026 Guide to Claims - LawFold.com
The article is presented as a 2026 guide to pursuing claims in Taxotere-related litigation.
Sanofi Gets Approval For Interlocutory Appeal In Taxotere MDL - Law360
Sanofi received permission to pursue an interlocutory appeal in the ongoing Taxotere multidistrict litigation.
In re Taxotere (Docetaxel) MDL Court Rejects Plaintiffs’ Argument that Lone Pine Order is Unfair - Faegre Drinker
The court overseeing the Taxotere multidistrict litigation rejected plaintiffs' challenge to a Lone Pine order.
Taxotere Lawsuit: August 2026 Updates & Vision Loss Claims - Drugwatch.com
The article provides an update on Taxotere litigation involving claims that the drug caused vision loss.
Curated matter facts are cited to public reporting and official sources and are not GPT-generated. Coverage above aggregates public news reporting using the GDELT news database and Google News, updated automatically without human review. It is general information, not legal advice, and does not indicate CaseValuation.com represents or is affiliated with any party, law firm, or plaintiff named above. CaseValuation.com is not a law firm. If you believe you're affected by one of these matters, consult a licensed attorney.